Title: Michael HÜMPEL - Innovator in Neurodegenerative Disease Treatment
Introduction
Michael HÜMPEL is an inventor based in Lübeck, Germany. He is associated with Berlirem GmbH, where he focuses on developing innovative solutions for medical challenges. His work primarily addresses the treatment of neurodegenerative diseases, particularly Parkinson's disease.
Latest Patent Applications
Michael HÜMPEL has submitted a patent application titled "Novel Kit of Pharmaceutical Preparations for the Treatment of Neurodegenerative Diseases." This invention aims to improve the treatment of Parkinson's patients who experience motor complications and require Continuous Dopaminergic Stimulation. The kit includes levodopa and an AADC-inhibitor, which are administered to enhance the effectiveness of the treatment while minimizing adverse effects. The application outlines a method for achieving effective Continuous Dopaminergic Stimulation through careful management of levodopa metabolism.
Conclusion
Michael HÜMPEL's contributions to the field of neurodegenerative disease treatment highlight his commitment to innovation in healthcare. His ongoing research and patent applications reflect a dedication to improving the quality of life for patients suffering from Parkinson's disease.